The mice were received three intravenous doses of EPA (60 μg/mouse) with four-day intervals started on day 10 accordinng to the MTT and MTD results in this and our previous study29, and three subcutaneous doses of gp100 melanoma vaccine (25 μg/mouse) with seven-day intervals started on day 7. This evidence concerns the gene PMEL and melanoma.